New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Elevation Oncology, Inc.
ELEV
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

29M

Biotechnology

Next Earning date - 01 May 2025

29M

Biotechnology

Next Earning date - 01 May 2025

0.65USD

Shape-0.03 ( -3.99%)
Market Closed (as of Feb 19, 21:00 EDT)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-69%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

89%

Quote Panel

Shape
Updated March 19, 2025
1W -3.41 % 1M -25.90 % 3M -16.98 % 1Y -88.91 %

Key Metrics

Shape
  • Market Cap

    28.51M


  • Shares Outstanding

    59.22M


  • Share in Float

    52.07M


  • Dividende

    0


  • Earning Date

    01 May 2025


  • Price Target

    0.4815


  • Average Volume

    2.25M


  • Beta

    1.382


  • Range

    0.415-5.83


  • Industry

    Biotechnology


  • Website

    https://elevationoncology.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

ELEV

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$0.79

Shape-340%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

William Blair

initialise

Previous: Not converted

2025-01-03

Now: Outperform

Piper Sandler

initialise

Previous: Not converted

2024-05-31

Now: Overweight

Stephens

initialise

Previous: Not converted

2024-05-13

Now: Overweight

Telsey Advisory

upgrade

Previous: Not converted

2023-05-30

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.50
vs -0.74

Q2.23

arrow
arrow

N/A

-0.37
vs -0.86

Q3.23

arrow
arrow

N/A

-0.25
vs -1.67

Q4.23

arrow
arrow

N/A

-0.19
vs -0.82

Q1.24

arrow
arrow

N/A

-0.23
vs -0.50

Q2.24

arrow
arrow

N/A

-0.18
vs -0.37

Q3.24

arrow
arrow

N/A

-0.22
vs -0.25

Q4.24

arrow
arrow

N/A

-0.18
vs -0.19

Q1.25

arrow
arrow

N/A

-0.20
vs -0.23

Q2.25

arrow
arrow

N/A

-0.21
vs -0.18

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

58K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-100%

NA  vs 58K

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-51%

-0.51
vs -0.39

Q2.23

arrow
arrow

-14%

-0.14
vs -0.51

Q3.23

arrow
arrow

-17%

-0.17
vs -0.14

Q4.23

arrow
arrow

-14%

-0.14
vs -0.17

Q1.24

arrow
arrow

-14%

-0.14
vs -0.14

Q2.24

arrow
arrow

-13%

-0.13
vs -0.14

Q3.24

arrow
arrow

-19%

-0.19
vs -0.13

Q4.24

arrow
arrow

-17%

-0.17
vs -0.19

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

27

27
vs 26

4%

Q2.23

arrow
arrow

40

40
vs 27

48%

Q3.23

arrow
arrow

40

40
vs 40

NA

Q4.23

arrow
arrow

31

31
vs 40

-22%

Q1.24

arrow
arrow

64

64
vs 31

106%

Q2.24

arrow
arrow

81

81
vs 64

27%

Q3.24

arrow
arrow

69

69
vs 81

-15%

Q4.24

arrow
arrow

72

72
vs 69

4%

Earnings Growth

Latest News